• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺癌T2*弛豫时间的估计:与临床、影像及病理特征的相关性

Estimation of T2* Relaxation Time of Breast Cancer: Correlation with Clinical, Imaging and Pathological Features.

作者信息

Seo Mirinae, Ryu Jung Kyu, Jahng Geon-Ho, Sohn Yu-Mee, Rhee Sun Jung, Oh Jang-Hoon, Won Kyu-Yeoun

机构信息

Department of Radiology, Kyung Hee University Hospital, College of Medicine, Kyung Hee University, Seoul 02447, Korea.

Department of Radiology, Kyung Hee University Hospital at Gangdong, College of Medicine, Kyung Hee University, Seoul 05278, Korea.

出版信息

Korean J Radiol. 2017 Jan-Feb;18(1):238-248. doi: 10.3348/kjr.2017.18.1.238. Epub 2017 Jan 5.

DOI:10.3348/kjr.2017.18.1.238
PMID:28096732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5240483/
Abstract

OBJECTIVE

The purpose of this study was to estimate the T2* relaxation time in breast cancer, and to evaluate the association between the T2* value with clinical-imaging-pathological features of breast cancer.

MATERIALS AND METHODS

Between January 2011 and July 2013, 107 consecutive women with 107 breast cancers underwent multi-echo T2*-weighted imaging on a 3T clinical magnetic resonance imaging system. The Student's test and one-way analysis of variance were used to compare the T2* values of cancer for different groups, based on the clinical-imaging-pathological features. In addition, multiple linear regression analysis was performed to find independent predictive factors associated with the T2* values.

RESULTS

Of the 107 breast cancers, 92 were invasive and 15 were ductal carcinoma (DCIS). The mean T2* value of invasive cancers was significantly longer than that of DCIS ( = 0.029). Signal intensity on T2-weighted imaging (T2WI) and histologic grade of invasive breast cancers showed significant correlation with T2* relaxation time in univariate and multivariate analysis. Breast cancer groups with higher signal intensity on T2WI showed longer T2* relaxation time ( = 0.005). Cancer groups with higher histologic grade showed longer T2* relaxation time ( = 0.017).

CONCLUSION

The T2* value is significantly longer in invasive cancer than in DCIS. In invasive cancers, T2* relaxation time is significantly longer in higher histologic grades and high signal intensity on T2WI. Based on these preliminary data, quantitative T2* mapping has the potential to be useful in the characterization of breast cancer.

摘要

目的

本研究旨在估计乳腺癌的T2弛豫时间,并评估T2值与乳腺癌临床-影像-病理特征之间的关联。

材料与方法

2011年1月至2013年7月期间,107例患有107个乳腺癌的连续女性患者在3T临床磁共振成像系统上接受了多回波T2加权成像。基于临床-影像-病理特征,采用Student's检验和单因素方差分析比较不同组别的癌症T2值。此外,进行多元线性回归分析以寻找与T2*值相关的独立预测因素。

结果

107个乳腺癌中,92个为浸润性癌,15个为导管原位癌(DCIS)。浸润性癌的平均T2值显著长于DCIS(P = 0.029)。在单因素和多因素分析中,浸润性乳腺癌的T2加权成像(T2WI)信号强度和组织学分级与T2弛豫时间显示出显著相关性。T2WI上信号强度较高的乳腺癌组显示出更长的T2弛豫时间(P = 0.005)。组织学分级较高的癌症组显示出更长的T2弛豫时间(P = 0.017)。

结论

浸润性癌的T2值显著长于DCIS。在浸润性癌中,组织学分级较高和T2WI上高信号强度的T2弛豫时间显著更长。基于这些初步数据,定量T2*成像有可能用于乳腺癌的特征描述。

相似文献

1
Estimation of T2* Relaxation Time of Breast Cancer: Correlation with Clinical, Imaging and Pathological Features.乳腺癌T2*弛豫时间的估计:与临床、影像及病理特征的相关性
Korean J Radiol. 2017 Jan-Feb;18(1):238-248. doi: 10.3348/kjr.2017.18.1.238. Epub 2017 Jan 5.
2
Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.弥散加权成像与 T2WI 联合应用,包括表观扩散系数在乳腺病变中的诊断价值:对组织学分级的评估。
Acad Radiol. 2018 May;25(5):643-652. doi: 10.1016/j.acra.2017.11.011. Epub 2018 Jan 12.
3
Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.计算机辅助乳腺磁共振成像评估导管原位癌异质性分析:与组织学分级和受体状态的相关性。
J Magn Reson Imaging. 2017 Dec;46(6):1748-1759. doi: 10.1002/jmri.25712. Epub 2017 Apr 3.
4
Ductal carcinoma in situ on digital mammography versus digital breast tomosynthesis: rates and predictors of pathologic upgrade.数字乳腺钼靶摄影与数字乳腺断层合成摄影中导管原位癌的检出率及其病理升级的预测因素。
Eur Radiol. 2020 Nov;30(11):6089-6098. doi: 10.1007/s00330-020-07021-2. Epub 2020 Jun 26.
5
Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?乳腺磁共振成像(MRI)是否有助于诊断近期诊断为单纯导管原位癌(DCIS)患者的其他病变部位?
Eur J Radiol. 2017 Nov;96:74-79. doi: 10.1016/j.ejrad.2017.09.014. Epub 2017 Sep 28.
6
Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer.乳腺特异性γ显像对粗针活检检测到的导管原位癌进展为浸润性癌的预测意义。
Ann Nucl Med. 2018 Jun;32(5):328-336. doi: 10.1007/s12149-018-1251-2. Epub 2018 Mar 19.
7
The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.动态对比增强磁共振成像和乳腺特异性γ成像对伴有钙化和非钙化导管原位癌女性的诊断敏感性
Acta Radiol. 2014 Jul;55(6):668-75. doi: 10.1177/0284185113505086. Epub 2013 Sep 16.
8
Apparent diffusion coefficient as an MR imaging biomarker of low-risk ductal carcinoma in situ: a pilot study.表观扩散系数作为低危型导管原位癌的 MRI 成像生物标志物:一项初步研究。
Radiology. 2011 Aug;260(2):364-72. doi: 10.1148/radiol.11101892. Epub 2011 Jun 1.
9
Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.西班牙两年一次的筛查性乳房 X 光检查中浸润性癌和导管原位癌检出率的变化趋势:一项回顾性队列研究。
PLoS One. 2013 Dec 23;8(12):e83121. doi: 10.1371/journal.pone.0083121. eCollection 2013.
10
Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent.纯导管内乳腺癌的术前磁共振成像——乳腺钼靶检查在评估癌症范围时的一项重要辅助手段。
Breast. 2008 Apr;17(2):186-94. doi: 10.1016/j.breast.2007.09.005. Epub 2007 Oct 26.

引用本文的文献

1
Peri-Tumoural Lipid Composition and Hypoxia for Early Immune Response to Neoadjuvant Chemotherapy in Breast Cancer.乳腺癌新辅助化疗早期免疫反应的肿瘤周围脂质组成和缺氧。
Int J Mol Sci. 2024 Aug 28;25(17):9303. doi: 10.3390/ijms25179303.
2
Multiparametric MRI model with synthetic MRI, DWI multi-quantitative parameters, and differential sub-sampling with cartesian ordering enables BI-RADS 4 lesions diagnosis with high accuracy.具有合成MRI、DWI多定量参数以及笛卡尔排序差分子采样的多参数MRI模型能够高精度诊断BI-RADS 4类病变。
Front Oncol. 2024 Jan 5;13:1180131. doi: 10.3389/fonc.2023.1180131. eCollection 2023.
3

本文引用的文献

1
Features of Undiagnosed Breast Cancers at Screening Breast MR Imaging and Potential Utility of Computer-Aided Evaluation.筛查乳腺磁共振成像中未诊断出的乳腺癌特征及计算机辅助评估的潜在效用
Korean J Radiol. 2016 Jan-Feb;17(1):59-68. doi: 10.3348/kjr.2016.17.1.59. Epub 2016 Jan 6.
2
Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype.根据分子亚型分析接受新辅助化疗患者乳腺MRI完全缓解的预后意义
Korean J Radiol. 2015 Sep-Oct;16(5):986-95. doi: 10.3348/kjr.2015.16.5.986. Epub 2015 Aug 21.
3
Imaging surveillance of patients with breast cancer after primary treatment: current recommendations.
Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status.
乳腺癌的合成磁共振成像:鉴别良恶性病变及预测免疫组化表达状态。
Sci Rep. 2023 Oct 20;13(1):17978. doi: 10.1038/s41598-023-45079-2.
4
Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration.铁氧化物纳米颗粒给药后肿瘤 T2*弛豫时间的测量。
J Vis Exp. 2023 May 19(195). doi: 10.3791/64773.
5
Can the apparent transverse relaxation rate (R2) evaluate the efficacy of concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma? a preliminary experience.表观横向弛豫率(R2)能否评估局部晚期鼻咽癌同期放化疗的疗效?初步经验。
BMC Med Imaging. 2023 Jun 1;23(1):69. doi: 10.1186/s12880-023-01029-y.
6
Cellular H MR Relaxation Times in Healthy and Cancer Three-Dimensional (3D) Breast Cell Culture.健康和癌症三维(3D)乳腺细胞培养中的细胞 H MR 弛豫时间。
Int J Mol Sci. 2023 Mar 1;24(5):4735. doi: 10.3390/ijms24054735.
7
Feasibility study of 2D Dixon-Magnetic Resonance Fingerprinting (MRF) of breast cancer.乳腺癌二维狄克逊磁共振指纹成像(MRF)的可行性研究。
Eur J Radiol Open. 2022 Nov 16;9:100453. doi: 10.1016/j.ejro.2022.100453. eCollection 2022.
8
Novel MR imaging nanoprobe for hepatocellular carcinoma detection based on manganese-zinc ferrite nanoparticles: in vitro and in vivo assessments.基于锰锌铁氧体纳米粒子的新型肝细胞癌检测磁共振成像纳米探针:体外和体内评估。
J Cancer Res Clin Oncol. 2023 Jul;149(8):4939-4957. doi: 10.1007/s00432-022-04427-x. Epub 2022 Oct 29.
9
Quantitative Values from Synthetic MRI Correlate with Breast Cancer Subtypes.合成磁共振成像的定量值与乳腺癌亚型相关。
Life (Basel). 2022 Aug 25;12(9):1307. doi: 10.3390/life12091307.
10
Breast Cancer Subtypes and Quantitative Magnetic Resonance Imaging: A Systemic Review.乳腺癌亚型与定量磁共振成像:一项系统综述
Life (Basel). 2022 Mar 28;12(4):490. doi: 10.3390/life12040490.
乳腺癌患者初始治疗后的影像监测:当前推荐意见
Korean J Radiol. 2015 Mar-Apr;16(2):219-28. doi: 10.3348/kjr.2015.16.2.219. Epub 2015 Feb 27.
4
Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio.在雌激素受体阳性的乳腺浸润性导管癌中:与肿瘤-间质比的相关性。
Radiology. 2014 Apr;271(1):30-7. doi: 10.1148/radiol.13131073. Epub 2013 Nov 21.
5
Relevance of hypoxia in radiation oncology: pathophysiology, tumor biology and implications for treatment.缺氧在放射肿瘤学中的相关性:病理生理学、肿瘤生物学及对治疗的影响
Q J Nucl Med Mol Imaging. 2013 Sep;57(3):219-34.
6
BOLD-MRI of breast invasive ductal carcinoma: correlation of R2* value and the expression of HIF-1α.乳腺浸润性导管癌的 BOLD-MRI:R2* 值与 HIF-1α 表达的相关性。
Eur Radiol. 2013 Dec;23(12):3221-7. doi: 10.1007/s00330-013-2937-4. Epub 2013 Jul 9.
7
Undiagnosed breast cancer at MR imaging: analysis of causes.磁共振成像中未诊断出的乳腺癌:原因分析。
Radiology. 2012 Jul;264(1):40-50. doi: 10.1148/radiol.12111917. Epub 2012 Apr 20.
8
Three-dimensional proton MR spectroscopic imaging at 3 T for the differentiation of benign and malignant breast lesions.3T 下三维质子磁共振波谱成像在良恶性乳腺病变鉴别诊断中的应用。
Radiology. 2011 Dec;261(3):752-61. doi: 10.1148/radiol.11102096. Epub 2011 Oct 13.
9
Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors.扩散加权成像对动态对比增强 MRI 在乳腺肿瘤特征描述中的作用。
AJR Am J Roentgenol. 2011 Jan;196(1):210-7. doi: 10.2214/AJR.10.4258.
10
American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.美国临床肿瘤学会/美国病理学家学会关于乳腺癌雌激素和孕激素受体免疫组织化学检测的指南建议。
J Oncol Pract. 2010 Jul;6(4):195-7. doi: 10.1200/JOP.777003. Epub 2010 Jun 23.